Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy

被引：0
|
作者：
Marcello Moccia
Giuseppina Affinito
Giulia Berera
Giuseppina Marrazzo
Raffaele Piscitelli
Antonio Carotenuto
Maria Petracca
Roberta Lanzillo
Maria Triassi
Vincenzo Brescia Morra
Raffaele Palladino
机构：
[1] University of Naples Federico II,Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology
[2] University of Naples Federico II,Department of Public Health
[3] ROCHE Spa,Department of Human Neurosciences
[4] Hospital Pharmacy ASL NA1 Centro,Department of Primary Care and Public Health
[5] Sapienza University,undefined
[6] Imperial College,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Multiple sclerosis; Ocrelizumab; Treatment; Persistence, adherence; Costs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6504 / 6511
页数：7
相关论文
共 50 条
  • [21] Comparison of real-world treatment patterns, persistence, healthcare resource utilization (HRU) and costs between octreotide and lanreotide for the treatment of neuroendocrine tumors (NET).
    Huynh, Lynn
    Cai, Beilei
    Sharperson, Camara
    Lejeune, Dominique
    Duh, Mei Sheng
    Kim, Michelle Kang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [22] Comparison of real-world treatment patterns, persistence, healthcare resource utilization (HRU) and costs between octreotide and Lanreotide for the treatment of neuroendocrine tumors (NET)
    Lynn Huynh
    Cai, Beilei
    Lejeune, Dominique
    Cheng, Mu
    Lax, Angie
    Duh, Mei S.
    Cheng, Wendy
    Kim, Michelle K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 134 - 134
  • [23] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND RELATED COSTS ASSOCIATED WITH ULTRARARE DISEASES IN THE BRAZILIAN PRIVATE MARKET
    Dos, Reis Neto J. P.
    Busch, J.
    VALUE IN HEALTH, 2024, 27 (12) : S591 - S591
  • [24] Real-world healthcare resource utilization and costs among patients with multiple myeloma in the United States.
    Gupta, Niodita
    Tai, Ming-Hui
    Kaila, Shuchita
    Thompson-Leduc, Philippe
    Ghelerter, Isabelle
    Kurteva, Siyana
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18811 - E18811
  • [25] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN CHINA
    Yang, K.
    Fan, Y.
    Chen, Y.
    Zhang, P.
    Lu, Y.
    Ban, L.
    He, Z.
    VALUE IN HEALTH, 2024, 27 (12) : S107 - S108
  • [26] REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF THE QUADRUPLE COMBINATION PERINDOPRIL, INDAPAMIDE, AMLODIPINE AND BISOPROLOL IN ITALY
    Mancia, Giuseppe
    Brouwers, Sofie
    Desideri, Giovambattista
    Esposti, Luca Degli
    Perrone, Valentina
    Narkiewicz, Krzysztof
    JOURNAL OF HYPERTENSION, 2023, 41 : E483 - E483
  • [27] Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
    Petrie, John L.
    Smith, Charlie A.
    Fountain, Donna
    Machnicki, Gerardo
    NEUROLOGY AND THERAPY, 2024, 13 (06) : 1597 - 1605
  • [28] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION OF RFVIIIFC VERSUS RFVIII IN HEMOPHILIA A
    Li, Nanxin
    Glazebrook, Desilu
    Su, Jun
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E38 - E38
  • [29] Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
    Studer, Sean
    Hull, Michael
    Pruett, Janis
    Koep, Eleena
    Tsang, Yuen
    Drake, William, III
    PULMONARY CIRCULATION, 2018, 9 (01)
  • [30] Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis
    Edson-Heredia, Emily
    Anderson, Seth
    Guo, Jiaying
    Zhu, Baojin
    Malatestinic, William N.
    Wine-Lee, Lara
    Swanson, Elizabeth
    ADVANCES IN THERAPY, 2021, 38 (07) : 3948 - 3961
12345